Trial site
K2 Medical Research - Maitland
- 12running trials
- 6closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease6 trials
- Depression3 trials
- Obesity3 trials
- Mild cognitive impairment2 trials
- Type 2 diabetes2 trials
- Bipolar disorder1 trial
- Frontotemporal dementia1 trial
- High blood pressure1 trial
- Parkinson disease1 trial
- Phase
- Phase 311 trials
- Phase 26 trials
- Phase 1/21 trial
- Status
- Recruiting7 trials
- Completed5 trials
- Active, not recruiting4 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Hoffmann-La Roche2 trials
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- Novo Nordisk A/S2 trials
- Alector Inc.1 trial
- and 4 more
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
Recruiting
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Recruiting
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Recruiting
Recruiting
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Active, not recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Depression2 recruiting
- Obesity2 recruiting
- Type 2 diabetes2 recruiting
- Bipolar disorder1 recruiting
- High blood pressure1 recruiting
- Parkinson disease1 recruiting
Closed trials
Completed
Completed
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Completed
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Terminated
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Site data: ClinicalTrials.govUpdated 15 Nov 2026